129 related articles for article (PubMed ID: 8258729)
1. [A study of first and second line chemotherapies in gestational choriocarcinoma].
Matsui H; Eguchi O; Inaba N; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1297-304. PubMed ID: 8258729
[TBL] [Abstract][Full Text] [Related]
2. [New combination chemotherapy against drug-resistant choriocarcinoma].
Matsui H; Kobayashi O; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1087-94. PubMed ID: 3611879
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
4. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Newlands ES
Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
[TBL] [Abstract][Full Text] [Related]
5. [The treatment of refractory choriocarcinoma].
Takamizawa Y; Inaba N; Matsui H
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1843-7. PubMed ID: 2393304
[TBL] [Abstract][Full Text] [Related]
6. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
[TBL] [Abstract][Full Text] [Related]
7. Salvage chemotherapy for high-risk gestational trophoblastic tumor.
Matsui H; Iitsuka Y; Suzuka K; Yamazawa K; Mitsuhashi A; Sekiya S
J Reprod Med; 2004 Jun; 49(6):438-42. PubMed ID: 15283050
[TBL] [Abstract][Full Text] [Related]
8. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
9. Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
Cancer; 2002 Sep; 95(5):1051-4. PubMed ID: 12209690
[TBL] [Abstract][Full Text] [Related]
10. Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Fujisawa M
Int J Urol; 2010 Oct; 17(10):881-5. PubMed ID: 20731738
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
Hartenbach EM; Saltzman AK; Carter JR; Twiggs LB
Gynecol Oncol; 1995 Jan; 56(1):105-8. PubMed ID: 7529741
[TBL] [Abstract][Full Text] [Related]
12. [Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour].
Xiang Y; Yang X; Han S
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):97-100. PubMed ID: 11263207
[TBL] [Abstract][Full Text] [Related]
13. [Fundamental and clinical study of chemotherapy of refractory choriocarcinoma].
Kobayashi O; Shirotake S; Matsui H; Sekiya S; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):79-86. PubMed ID: 3819516
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
Sato S; Yamamoto E; Niimi K; Ino K; Nishino K; Suzuki S; Kotani T; Kajiyama H; Kikkawa F
Int J Clin Oncol; 2020 Jan; 25(1):203-209. PubMed ID: 31520175
[TBL] [Abstract][Full Text] [Related]
15. [Study on the rationale for chemotherapy of refractory choriocarcinoma].
Katoh T; Ishige H; Kobayashi O; Takamizawa H
Gan To Kagaku Ryoho; 1982 May; 9(5):815-21. PubMed ID: 6191704
[TBL] [Abstract][Full Text] [Related]
16. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
17. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
18. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
Mortakis AE; Braga CA
Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Wang S; An R; Han X; Zhu K; Xue Y
Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
